Skip to main content
. 2017 Jan 9;7:39528. doi: 10.1038/srep39528

Table 2. Relationship between pri-let-7e rs8111742, pri-miR-365b rs121224, pri-miR-4795 rs1002765 and risk of atrophic gastritis and gastric cancer.

  Control group (%) Atrophic gastritis group (%) Atrophic gastritis group vs. control group
Control group (%) Cancer group (%) Cancer group vs. control group
P OR(95%CI) P OR(95%CI)
  n = 862 n = 862     n = 729 n = 724    
pri-let7e rs8111742
 GG 459(53.2) 458(53.1)   1.00 389(53.4) 375(51.8)   1.00
 GA 341(39.6) 343(39.8) 0.921 1.01(0.82–1.25) 285(39.1) 291(40.2) 0.690 1.05(0.84–1.31)
 AA 62(7.2) 61(7.1) 0.987 1.00(0.67–1.48) 55(7.5) 58(8.0) 0.795 1.06(0.70–1.59)
 AA + GA vs. GG     0.927 1.01(0.83–1.23)     0.667 1.05(0.85–1.30)
 AA vs. GA + GG     0.984 1.00(0.68–1.47)     0.854 1.04(0.70–1.54)
 A vs. G     0.929 1.01(0.86–1.18)     0.658 1.04(0.88–1.23)
 HWPa 0.185 0.778     0.78 0.882    
pri-miR-365b rs121224
 CC 270(31.3) 272(31.6)   1.00 229(31.4) 221(30.5)   1.00
 CG 428(49.7) 413(47.9) 0.436 0.91(0.73–1.15) 362(49.7) 376(51.9) 0.630 1.06(0.83–1.35)
 GG 164(19.0) 177(20.5) 0.604 1.08(0.81–1.43) 138(18.9) 127(17.5) 0.806 0.96(0.70–1.32)
 CG + GG vs. CC     0.695 0.96(0.77–1.19)     0.773 1.03(0.82–1.30)
 GG vs. CG + CC     0.334 1.13(0.88–1.45)     0.593 0.93(0.71–1.22)
 G vs. C     0.730 1.03(0.89–1.18)     0.963 1.00(0.86–1.16)
 HWPa 0.8 0.3     0.811 0.129    
pri-miR4795 rs1002765
 GG 307(35.6) 304(35.3)   1.00 262(35.9) 272(37.6)   1.00
 GA 420(48.7) 416(48.3) 0.766 1.03(0.83–1.29) 357(49.0) 349(48.2) 0.619 0.94(0.75–1.19)
 AA 135(15.7) 142(16.5) 0.654 1.07(0.79–1.45) 110(15.1) 103(14.2) 0.703 0.94(0.67–1.30)
 AA + GA vs. GG     0.694 1.04(0.85–1.28)     0.590 0.94(0.76–1.17)
 AA vs. GA + GG     0.721 1.05(0.80–1.38)     0.774 0.96(0.71–1.29)
 A vs. G     0.638 1.04(0.90–1.20)     0.609 0.96(0.82–1.12)
 HWPa 0.662 0.988     0.518 0.597    

Note: aHardyWeinberg balance in the crowd.